Cell augmentation strategies for cardiac stem cell therapies.


Journal

Stem cells translational medicine
ISSN: 2157-6580
Titre abrégé: Stem Cells Transl Med
Pays: England
ID NLM: 101578022

Informations de publication

Date de publication:
06 2021
Historique:
revised: 06 01 2021
received: 30 10 2020
accepted: 12 01 2021
pubmed: 5 3 2021
medline: 24 3 2022
entrez: 4 3 2021
Statut: ppublish

Résumé

Myocardial infarction (MI) has been the primary cause of death in developed countries, resulting in a major psychological and financial burden for society. Current treatments for acute MI are directed toward rapid restoration of perfusion to limit damage to the myocardium, rather than promoting tissue regeneration and subsequent contractile function recovery. Regenerative cell therapies (CTs), in particular those using multipotent stem cells (SCs), are in the spotlight for treatment post-MI. Unfortunately, the efficacy of CTs is somewhat limited by their poor long-term viability, homing, and engraftment to the myocardium. In response, a range of novel SC-based technologies are in development to provide additional cellular modalities, bringing CTs a step closer to the clinic. In this review, the current landscape of emerging CTs and their augmentation strategies for the treatment post-MI are discussed. In doing so, we highlight recent advances in cell membrane reengineering via genetic modifications, recombinant protein immobilization, and the utilization of soft biomimetic scaffold interfaces.

Identifiants

pubmed: 33660953
doi: 10.1002/sctm.20-0489
pmc: PMC8133336
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

855-866

Subventions

Organisme : Medical Research Council
ID : MR/S016430/1
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals LLC on behalf of AlphaMed Press.

Références

Transplantation. 2010 Aug 27;90(4):364-72
pubmed: 20555308
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Cell Death Differ. 2017 Dec;24(12):2101-2116
pubmed: 28800128
J Surg Res. 2000 Apr;89(2):189-95
pubmed: 10729249
Gene Ther. 2015 Jun;22(6):449-57
pubmed: 25789461
Exp Biol Med (Maywood). 2016 May;241(10):1098-106
pubmed: 27229904
Cardiovasc Res. 2020 Oct 1;116(12):1971
pubmed: 32556096
Mol Ther Methods Clin Dev. 2020 Apr 18;17:986-998
pubmed: 32426414
Circulation. 2002 Jan 1;105(1):93-8
pubmed: 11772882
Pharmacol Ther. 2017 Mar;171:1-12
pubmed: 27916652
Circulation. 2001 Aug 28;104(9):1046-52
pubmed: 11524400
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14022-7
pubmed: 19666564
Cell Death Dis. 2019 Jun 4;10(6):436
pubmed: 31164633
Nature. 2001 Apr 5;410(6829):701-5
pubmed: 11287958
Circ Heart Fail. 2015 Mar;8(2):333-41
pubmed: 25632037
Mol Ther. 2008 Mar;16(3):571-9
pubmed: 18253156
Nature. 2012 Sep 13;489(7415):322-5
pubmed: 22864415
Circulation. 2008 Sep 30;118(14 Suppl):S145-52
pubmed: 18824746
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Shock. 2010 Jan;33(1):24-30
pubmed: 19996917
Stem Cell Rev Rep. 2019 Apr;15(2):166-175
pubmed: 30623359
Sci Adv. 2018 Nov 28;4(11):eaat9365
pubmed: 30498778
Front Cell Dev Biol. 2020 Aug 21;8:737
pubmed: 32974331
Bioconjug Chem. 2017 May 17;28(5):1544-1551
pubmed: 28437083
Eur Heart J. 2009 Nov;30(22):2722-32
pubmed: 19586959
Biochem Biophys Res Commun. 2007 May 11;356(3):780-4
pubmed: 17382293
Adv Healthc Mater. 2020 Aug;9(15):e1900554
pubmed: 31407502
JAMA Cardiol. 2016 Oct 1;1(7):831-841
pubmed: 27557438
Chem Sci. 2019 Jul 3;10(32):7610-7618
pubmed: 31588312
Biochem Biophys Res Commun. 2010 Oct 29;401(4):509-15
pubmed: 20869949
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1168-73
pubmed: 15831811
Cell Prolif. 2015 Dec;48(6):661-70
pubmed: 26466964
Sci Adv. 2020 Mar 25;6(13):eaay6994
pubmed: 32284967
Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2129-39
pubmed: 17660391
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8538-8543
pubmed: 28739907
Int J Mol Sci. 2020 Oct 26;21(21):
pubmed: 33114544
Biomaterials. 2012 Jul;33(20):5004-12
pubmed: 22494889
Stem Cell Res Ther. 2020 Mar 26;11(1):136
pubmed: 32216819
Circ Res. 2011 Sep 30;109(8):910-22
pubmed: 21960724
Cell Prolif. 2017 Apr;50(2):
pubmed: 27878916
Biotechnology (N Y). 1990 Sep;8(9):854-6
pubmed: 1366797
Cytotherapy. 2019 Jan;21(1):3-16
pubmed: 30473313
Haematologica. 2007 Jul;92(7):897-904
pubmed: 17606439
Nature. 2018 May;557(7707):619-620
pubmed: 29844563
Nature. 2016 Oct 20;538(7625):388-391
pubmed: 27723741
J Endovasc Ther. 2002 Jun;9(3):313-9
pubmed: 12096946
Int J Cardiol. 2015 Dec 15;201:517-28
pubmed: 26322599
World J Stem Cells. 2016 Mar 26;8(3):73-87
pubmed: 27022438
Adv Exp Med Biol. 2017;998:221-235
pubmed: 28936743
Bioeng Transl Med. 2019 Oct 22;5(1):e10147
pubmed: 31989036
Am J Transl Res. 2013 May 24;5(4):404-11
pubmed: 23724164
Acta Cardiol. 2005 Jun;60(3):277-84
pubmed: 15999467
Nat Protoc. 2012 Apr 05;7(5):850-8
pubmed: 22481530
Biomaterials. 2010 Jul;31(19):5266-74
pubmed: 20381141
PLoS One. 2017 May 11;12(5):e0173222
pubmed: 28493867
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1268-76
pubmed: 26293548
Circ Res. 2018 Jul 6;123(2):266-287
pubmed: 29976692
Acta Biomater. 2018 Oct 15;80:154-168
pubmed: 30218777
Circ Res. 2008 May 9;102(9):1008-10
pubmed: 18436793
J Am Coll Cardiol. 2015 Nov 3;66(18):1990-1999
pubmed: 26516002
J Am Coll Cardiol. 2018 Jan 30;71(4):429-438
pubmed: 29389360
Biomaterials. 2012 Apr;33(11):3093-106
pubmed: 22265788
J Mol Cell Cardiol. 2008 Feb;44(2):281-92
pubmed: 18201717
Circ Res. 2011 Apr 1;108(7):792-6
pubmed: 21415390
Sci Transl Med. 2020 Apr 8;12(538):
pubmed: 32269164
Mol Neurobiol. 2013 Apr;47(2):811-20
pubmed: 23288365
J Clin Invest. 2009 Aug;119(8):2204-17
pubmed: 19620770
Macromol Biosci. 2017 Jul;17(7):
pubmed: 28233419
J Mol Cell Cardiol. 2010 Dec;49(6):941-9
pubmed: 20854826
Cell Mol Immunol. 2012 Nov;9(6):473-81
pubmed: 23085948
Circulation. 2003 Aug 19;108(7):863-8
pubmed: 12900340
Annu Rev Physiol. 1999;61:219-42
pubmed: 10099688
J Biol Eng. 2018 Dec 4;12:28
pubmed: 30524502
Stem Cells. 2011 Oct;29(10):1549-58
pubmed: 21898680
Cell. 2010 Aug 6;142(3):375-86
pubmed: 20691899
J Mol Cell Cardiol. 2008 Oct;45(4):514-22
pubmed: 18304573
Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H976-86
pubmed: 19181961
Theranostics. 2017 Sep 26;7(17):4168-4182
pubmed: 29158817
Circ Res. 2018 Apr 13;122(8):1151-1163
pubmed: 29650632
Stem Cells. 2008 Apr;26(4):1083-93
pubmed: 18203678
Cell Stem Cell. 2009 Jul 2;5(1):54-63
pubmed: 19570514
Lancet. 2003 Jan 4;361(9351):45-6
pubmed: 12517467
Annu Rev Med. 2017 Jan 14;68:1-13
pubmed: 27686020
Transplantation. 2019 Feb;103(2):291-298
pubmed: 30119058
Cells Tissues Organs. 2001;169(1):12-20
pubmed: 11340257
Circ Res. 2018 Jun 8;122(12):1703-1715
pubmed: 29703749
ACS Appl Bio Mater. 2020 May 18;3(5):2930-2939
pubmed: 33225239
J Thorac Cardiovasc Surg. 2005 Nov;130(5):1333-41
pubmed: 16256786
JAMA. 2012 Dec 12;308(22):2369-79
pubmed: 23117550
Circ Res. 2015 Apr 10;116(8):1361-77
pubmed: 25632038
J Cell Mol Med. 2007 Sep-Oct;11(5):1087-100
pubmed: 17979884
Circ Heart Fail. 2018 Oct;11(10):e005425
pubmed: 30354396
Stem Cell Res. 2007 Oct;1(1):9-24
pubmed: 19383383
Sci Adv. 2020 Jul 22;6(30):eaba6884
pubmed: 32832666
Interact Cardiovasc Thorac Surg. 2007 Oct;6(5):593-7
pubmed: 17670726
Blood. 2009 Jan 22;113(4):816-26
pubmed: 18818395
Cell Tissue Kinet. 1970 Oct;3(4):393-403
pubmed: 5523063
Stem Cell Res Ther. 2019 Jun 27;10(1):194
pubmed: 31248454
Cell Mol Life Sci. 2010 Jan;67(2):277-90
pubmed: 19844658
Nat Rev Cardiol. 2010 Jan;7(1):30-7
pubmed: 19949426
J Transl Med. 2020 Sep 1;18(1):336
pubmed: 32873307
Nat Med. 2003 Sep;9(9):1195-201
pubmed: 12910262
J Artif Organs. 2008;11(3):141-7
pubmed: 18836875
J Thorac Cardiovasc Surg. 2019 Apr;157(4):1479-1490
pubmed: 30579534
Adv Funct Mater. 2015 Mar 4;25(9):1344-1351
pubmed: 26273242
Stem Cells. 2005 Mar;23(3):355-64
pubmed: 15749930
Stem Cells. 2007 Aug;25(8):2118-27
pubmed: 17478584
Macromol Biosci. 2018 Jun;18(6):e1800079
pubmed: 29733514
Nat Commun. 2015 Jun 17;6:7405
pubmed: 26080734
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Artif Cells Nanomed Biotechnol. 2016 Nov;44(7):1665-70
pubmed: 26376009
Front Immunol. 2019 Jan 31;10:43
pubmed: 30804926
Cell Stem Cell. 2009 Mar 6;4(3):206-16
pubmed: 19265660
Leukemia. 2003 Jan;17(1):160-70
pubmed: 12529674
Biomaterials. 2013 Nov;34(33):8213-22
pubmed: 23891082
Pharmacol Ther. 2016 Nov;167:100-107
pubmed: 27484974
Exp Hematol. 2006 Aug;34(8):967-75
pubmed: 16863903
Acta Biomater. 2019 Mar 1;86:223-234
pubmed: 30660010
Theranostics. 2012;2(4):335-45
pubmed: 22509197
Nature. 2020 Jan;577(7790):405-409
pubmed: 31775156
Nat Commun. 2019 Apr 23;10(1):1887
pubmed: 31015421
Biomaterials. 2014 Jul;35(21):5627-35
pubmed: 24731711
Stem Cells Transl Med. 2021 Jun;10(6):855-866
pubmed: 33660953
Circulation. 2013 Jan 15;127(2):213-23
pubmed: 23224061
J Pathol. 2009 Jan;217(2):318-24
pubmed: 19023885
Circulation. 2005 Aug 30;112(9 Suppl):I150-6
pubmed: 16159808
J Card Fail. 2017 May;23(5):403-415
pubmed: 28284757
Eur Heart J. 2015 Sep 7;36(34):2297-309
pubmed: 26082085
Transplant Proc. 2007 Mar;39(2):573-6
pubmed: 17362785
J Am Coll Cardiol. 2005 Oct 4;46(7):1339-50
pubmed: 16198853
Sci Rep. 2018 Jan 25;8(1):1579
pubmed: 29371689
Stem Cell Res Ther. 2020 Feb 21;11(1):73
pubmed: 32085809
Cell Cycle. 2018;17(8):927-946
pubmed: 29862928
Nat Biotechnol. 2018 Aug;36(7):597-605
pubmed: 29969440
Adv Healthc Mater. 2016 Jul;5(14):1724-30
pubmed: 27125336
Circulation. 2012 Sep 11;126(11 Suppl 1):S29-37
pubmed: 22965990
Curr Opin Organ Transplant. 2015 Dec;20(6):663-70
pubmed: 26536430
Circ Res. 2015 Apr 10;116(8):1413-30
pubmed: 25858066
Hepatology. 2016 Aug;64(2):632-43
pubmed: 26773713
Cell Transplant. 2007;16(9):927-34
pubmed: 18293891
Nature. 2014 Jun 12;510(7504):273-7
pubmed: 24776797
PLoS One. 2015 Jul 10;10(7):e0131446
pubmed: 26161513
Biomaterials. 2014 Mar;35(8):2436-45
pubmed: 24378015
Perfusion. 2019 Nov;34(8):696-704
pubmed: 31090492

Auteurs

Raquel Cruz-Samperio (R)

School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.

Millie Jordan (M)

School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.

Adam Perriman (A)

School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH